Electromed, Inc. (ELMD) Financial Ratios
18 years of historical data (2008–2025) · Healthcare · Medical - Devices
EV/EBITDA
↓
27.63
↑+45% vs avg
5yr avg: 19.06
30Y Low6.2·High23.7
P/FCF
↓
28.89
↑+22% vs avg
5yr avg: 23.64
30Y Low7.0·High92.8
P/B Ratio
↑
7.80
↑+152% vs avg
5yr avg: 3.10
30Y Low0.7·High4.5
ROE
↑
17.2%
↓+62% vs avg
5yr avg: 10.6%
30Y Low-10%·High26%
Debt/EBITDA
↓
0.02
↓-10% vs avg
5yr avg: 0.02
30Y Low0.0·High5.1
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
ELMD Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Electromed, Inc. trades at 45.0x earnings, 40% above its 5-year average of 32.0x, sitting at the 92nd percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 103%. On a free-cash-flow basis, the stock trades at 28.9x P/FCF, 22% above the 5-year average of 23.6x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $320M | $192M | $133M | $93M | $85M | $101M | $136M | $47M | $47M | $47M | $32M |
| Enterprise Value | $305M | $177M | $117M | $86M | $76M | $89M | $125M | $39M | $40M | $42M | $28M |
| P/E Ratio → | 44.98 | 25.57 | 25.91 | 29.75 | 37.08 | 41.81 | 32.74 | 23.70 | 24.64 | 21.27 | 14.30 |
| P/S Ratio | 5.00 | 3.00 | 2.44 | 1.94 | 2.03 | 2.81 | 4.18 | 1.50 | 1.65 | 1.81 | 1.38 |
| P/B Ratio | 7.80 | 4.44 | 2.99 | 2.47 | 2.47 | 3.10 | 4.49 | 1.83 | 2.13 | 2.45 | 1.95 |
| P/FCF | 28.89 | 17.29 | 15.36 | — | — | 38.27 | 42.20 | 39.15 | 24.98 | 92.84 | 20.03 |
| P/OCF | 28.11 | 16.83 | 14.69 | 70.86 | — | 32.70 | 32.37 | 18.16 | 19.13 | 39.28 | 14.69 |
P/E links to full P/E history page with 30-year chart
ELMD EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Electromed, Inc.'s enterprise value stands at 27.6x EBITDA, 45% above its 5-year average of 19.1x. The Healthcare sector median is 14.2x, placing the stock at a 94% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.76 | 2.14 | 1.79 | 1.83 | 2.48 | 3.86 | 1.25 | 1.43 | 1.64 | 1.21 |
| EV / EBITDA | 27.63 | 15.99 | 15.80 | 18.61 | 21.23 | 23.68 | 21.41 | 10.46 | 11.53 | 9.80 | 7.26 |
| EV / EBIT | 30.91 | 17.89 | 17.82 | 21.45 | 25.71 | 28.28 | 24.51 | 13.88 | 14.88 | 11.87 | 8.98 |
| EV / FCF | — | 15.93 | 13.52 | — | — | 33.78 | 38.97 | 32.69 | 21.58 | 84.06 | 17.57 |
ELMD Profitability
Margins and return-on-capital ratios measuring operating efficiency
Electromed, Inc. earns an operating margin of 15.4%. Operating margins have expanded from 8.3% to 15.4% over the past 3 years, signaling improving operational efficiency. ROE of 17.2% indicates solid capital efficiency. ROIC of 26.1% represents excellent returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.1% | 78.1% | 76.3% | 76.0% | 75.5% | 76.4% | 77.6% | 76.2% | 76.9% | 79.5% | 77.7% |
| Operating Margin | 15.4% | 15.4% | 12.0% | 8.3% | 7.1% | 8.8% | 15.8% | 9.0% | 9.6% | 13.8% | 13.5% |
| Net Profit Margin | 11.8% | 11.8% | 9.4% | 6.6% | 5.5% | 6.6% | 12.8% | 6.3% | 6.5% | 8.6% | 9.6% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 17.2% | 17.2% | 12.5% | 8.8% | 6.9% | 7.5% | 14.9% | 8.3% | 8.9% | 12.6% | 14.6% |
| ROA | 14.2% | 14.2% | 10.5% | 7.3% | 5.9% | 6.7% | 13.3% | 7.1% | 7.4% | 10.2% | 11.6% |
| ROIC | 26.1% | 26.1% | 16.7% | 10.6% | 9.6% | 11.6% | 20.3% | 12.7% | 13.5% | 19.8% | 19.4% |
| ROCE | 22.5% | 22.5% | 16.0% | 11.1% | 8.9% | 10.0% | 18.3% | 11.9% | 12.9% | 18.9% | 19.1% |
ELMD Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Electromed, Inc. carries a Debt/EBITDA ratio of 0.0x, which is very conservative (99% below the sector average of 3.2x). The company holds a net cash position — cash of $15M exceeds total debt of $198000, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.06 | 0.07 |
| Debt / EBITDA | 0.02 | 0.02 | 0.01 | 0.03 | 0.01 | 0.02 | 0.01 | 0.01 | 0.31 | 0.27 | 0.31 |
| Net Debt / Equity | — | -0.35 | -0.36 | -0.19 | -0.24 | -0.36 | -0.34 | -0.30 | -0.29 | -0.23 | -0.24 |
| Net Debt / EBITDA | -1.37 | -1.37 | -2.15 | -1.56 | -2.25 | -3.15 | -1.77 | -2.07 | -1.81 | -1.02 | -1.02 |
| Debt / FCF | — | -1.36 | -1.84 | — | — | -4.49 | -3.23 | -6.46 | -3.40 | -8.78 | -2.47 |
| Interest Coverage | — | — | — | — | — | — | — | — | — | 53.34 | 46.54 |
Net cash position: cash ($15M) exceeds total debt ($198000)
ELMD Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Electromed, Inc.'s current ratio of 4.31x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 3.99x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 4.69x to 4.31x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.31 | 4.31 | 5.75 | 4.69 | 4.83 | 6.83 | 9.38 | 6.78 | 4.68 | 6.38 | 5.15 |
| Quick Ratio | 3.99 | 3.99 | 5.27 | 4.17 | 4.39 | 6.38 | 8.35 | 6.05 | 4.19 | 5.50 | 4.34 |
| Cash Ratio | 1.46 | 1.46 | 2.09 | 0.92 | 1.14 | 2.56 | 3.51 | 2.16 | 1.57 | 1.92 | 1.67 |
| Asset Turnover | — | 1.19 | 1.05 | 1.05 | 1.01 | 0.96 | 0.98 | 1.07 | 1.06 | 1.12 | 1.12 |
| Inventory Turnover | 4.25 | 4.25 | 3.50 | 2.74 | 3.21 | 4.00 | 2.36 | 2.84 | 2.77 | 2.07 | 2.06 |
| Days Sales Outstanding | — | 146.55 | 160.45 | 186.93 | 186.96 | 177.88 | 155.62 | 160.41 | 162.31 | 140.43 | 123.89 |
ELMD Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Electromed, Inc. returns 3.1% to shareholders annually primarily through share buybacks. The earnings yield of 2.2% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.2% | 3.9% | 3.9% | 3.4% | 2.7% | 2.4% | 3.1% | 4.2% | 4.1% | 4.7% | 7.0% |
| FCF Yield | 3.5% | 5.8% | 6.5% | — | — | 2.6% | 2.4% | 2.6% | 4.0% | 1.1% | 5.0% |
| Buyback Yield | 3.1% | 5.2% | 0.2% | 0.2% | 1.7% | 1.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 3.1% | 5.2% | 0.2% | 0.2% | 1.7% | 1.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $8M | $8M |
Peer Comparison
Compare ELMD with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 ELMDYou | $320M | 45.0 | 27.6 | 28.9 | 78.1% | 15.4% | 17.2% | 26.1% | 0.0 |
 INGN | $174M | -7.5 | — | — | 47.6% | -8.7% | -12.4% | -24.4% | — |
 LNTH | $7B | 30.5 | 16.8 | 19.1 | 61.1% | 20.2% | 21.4% | 30.6% | 0.0 |
 LUNG | $54M | -1.0 | — | — | 74.2% | -59.3% | -77.2% | -72.0% | — |
 SPXC | $12B | 48.0 | 24.5 | 50.5 | 36.7% | 16.8% | 13.6% | 13.4% | 1.0 |
 ABT | $154B | 11.6 | 16.1 | 24.2 | 50.8% | 16.3% | 30.9% | 9.9% | 1.5 |
 MDT | $102B | 22.0 | 14.5 | 19.6 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 PHG | $25B | 25.2 | 10.8 | 24.9 | 45.2% | 8.0% | 7.8% | 6.4% | 3.2 |
 HOLX | $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 |
 NVCR | $2B | -11.7 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 MASI | $9B | -64.3 | 28.0 | 47.6 | 61.9% | 20.5% | -17.1% | 16.5% | 1.6 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 18 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
ELMD — Frequently Asked Questions
Quick answers to the most common questions about buying ELMD stock.
What is Electromed, Inc.'s P/E ratio?
Electromed, Inc.'s current P/E ratio is 45.0x. The historical average is 32.4x. This places it at the 92th percentile of its historical range.
What is Electromed, Inc.'s EV/EBITDA?
Electromed, Inc.'s current EV/EBITDA is 27.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 14.6x.
What is Electromed, Inc.'s ROE?
Electromed, Inc.'s return on equity (ROE) is 17.2%. The historical average is 8.8%.
Is ELMD stock overvalued?
Based on historical data, Electromed, Inc. is trading at a P/E of 45.0x. This is at the 92th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Electromed, Inc.'s profit margins?
Electromed, Inc. has 78.1% gross margin and 15.4% operating margin. Operating margin between 10-20% is typical for established companies.
How much debt does Electromed, Inc. have?
Electromed, Inc.'s Debt/EBITDA ratio is 0.0x, indicating low leverage. A ratio below 2x is generally considered financially healthy.